av/inventiva--big.svg

COM:INVENTIVAPHARMA

Inventiva Pharma

  • Stock

Last Close

2.58

21/11 16:35

Market Cap

125.95M

Beta: -

Volume Today

19.73K

Avg: -

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has c...Show More

peer of

investor of

competitor of